{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["3(Suppl 2)"],"submitter":["Dillman R"],"journal":["Journal for immunotherapy of cancer"],"pagination":["P202-P202"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4649581"],"repository":["biostudies-literature"],"pubmed_title":["Superiority of dendritic cell vaccine vs tumor cell vaccine: survival by stratification subsets in MACVAC randomized Phase II trial of patient-specific vaccines utilizing antigens from autologous melanoma tumor cell lines"],"pmcid":["PMC4649581"],"pubmed_authors":["Dillman R","Burtzo D","Amatruda T","Carbonell D","Cornforth A","Semeniuk G","McClay E","DePriest C","Haskins C","Weber R"],"additional_accession":[]},"is_claimable":false,"name":"Superiority of dendritic cell vaccine vs tumor cell vaccine: survival by stratification subsets in MACVAC randomized Phase II trial of patient-specific vaccines utilizing antigens from autologous melanoma tumor cell lines","description":null,"dates":{"release":"2015-01-01T00:00:00Z","publication":"2015 Jan","modification":"2025-04-26T19:31:01.974Z","creation":"2025-04-06T16:05:09.049Z"},"accession":"S-EPMC4649581","cross_references":{}}